Adagio Therapeutics, Inc. (ADGI): Price and Financial Metrics

Adagio Therapeutics, Inc. (ADGI): $4.64

0.04 (+0.87%)

POWR Rating

Component Grades

Momentum

F

Stability

C

Sentiment

Quality

D

Add ADGI to Watchlist
Sign Up

Industry: Biotech

Industry

NR

Ranked

#317 of 398

in industry

ADGI Price/Volume Stats

Current price $4.64 52-week high $78.82
Prev. close $4.60 52-week low $2.41
Day low $4.40 Volume 536,300
Day high $4.74 Avg. volume 2,269,922
50-day MA $4.13 Dividend yield N/A
200-day MA $6.92 Market Cap 504.98M

ADGI Stock Price Chart Interactive Chart >


Adagio Therapeutics, Inc. (ADGI) Company Bio


Adagio Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of antibody-based solutions for infectious diseases in the United States. Its lead product candidate is the ADG20, a neutralizing antibody that is in Phase II/III clinical trials for the treatment and prevention of coronavirus disease. The company has a collaboration agreement with Adimab, LLC for the discovery and optimization of proprietary antibodies. Adagio Therapeutics, Inc. was incorporated in 2020 and is based in Waltham, Massachusetts.


ADGI Latest News Stream


Event/Time News Detail
Loading, please wait...

ADGI Latest Social Stream


Loading social stream, please wait...

View Full ADGI Social Stream

ADGI Price Returns

1-mo N/A
3-mo N/A
6-mo N/A
1-year N/A
3-year -75.87%
5-year N/A
YTD N/A
2023 N/A
2022 0.00%
2021 N/A
2020 N/A
2019 N/A

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!